Targeting energy metabolism of cancer cells: Combined administration of NCL-240 and 2-DG

This publication has 41 references indexed in Scilit:

• Targeting cellular metabolism to improve cancer therapeutics
  Cell Death & Disease, 2013
• Combination of glycolysis inhibition with chemotherapy results in an antitumor immune response
  Proceedings of the National Academy of Sciences, 2012
• Tumor Metastasis: Molecular Insights and Evolving Paradigms
  Cell, 2011
• Reversal of multidrug resistance by co-delivery of tariquidar (XR9576) and paclitaxel using long-circulating liposomes
  International Journal of Pharmaceutics, 2011
• Antiangiogenic Activity of 2-Deoxy-D-Glucose
  PLOS ONE, 2010
• 2-Deoxy-d-glucose activates autophagy via endoplasmic reticulum stress rather than ATP depletion
  Cancer Chemotherapy and Pharmacology, 2010
• HMDB: a knowledgebase for the human metabolome
  Nucleic Acids Research, 2008
• Oxythiamine and dehydroepiandrosterone induce a G₁ phase cycle arrest in Ehrlich's tumor cells through inhibition of the pentose cycle
  FEBS Letters, 1999
• Improving cancer radiotherapy with 2-deoxy-d-glucose: phase I/II clinical trials on human cerebral gliomas
  International Journal of Radiation Oncology - Biology - Physics (IJROBP), 1996
• On the Origin of Cancer Cells
  Science, 1956